메뉴 건너뛰기
International Journal of Dermatology
Volumn 36, Issue 12, 1997, Pages 908-910
The progression of nonsegmental vitiligo: Clinical analysis of 318 patients
Author keywords

[No Author keywords available]
Indexed keywords

ARTICLE; DISEASE COURSE; FACE; HAND; HUMAN; MAJOR CLINICAL STUDY; NECK; TRUNK; VITILIGO;
EID: 2642678434     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00320.x     Document Type: Article
Times cited : (19)
References (12)
  • 1
    • 0001136083 scopus 로고
    • Vitiligo: Etiology, pathogenesis, diagnosis, and treatment
    • Fitzpatrick TB, Eisen AZ, Wolff K, et al., eds. New York: McGraw-Hill
    • Moscher DB. Vitiligo: etiology, pathogenesis, diagnosis, and treatment. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., eds. Update: Dermatology in General Medicine. New York: McGraw-Hill, 1983; 205-225.
    • (1983) Update: Dermatology in General Medicine , pp. 205-225
    • Moscher, D.B.1
  • 3
    • 0017668661 scopus 로고
    • Vitiligo: A new classification and therapy
    • Koga M. Vitiligo: a new classification and therapy. Br J Dermatol 1977; 97: 255-261.
    • (1977) Br J Dermatol , vol.97 , pp. 255-261
    • Koga, M.1
  • 4
    • 0023944653 scopus 로고
    • Clinical feature and course of type A and type B vitiligo
    • Koga M, Tango T. Clinical feature and course of type A and type B vitiligo. Br J Dermatol 1988; 118: 223-228.
    • (1988) Br J Dermatol , vol.118 , pp. 223-228
    • Koga, M.1    Tango, T.2
  • 6
    • 0041590411 scopus 로고    scopus 로고
    • Segmental vitiligo: Clinical findings in 208 patients
    • Hann SK, Lee HJ. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 1996; 35: 671-674.
    • (1996) J Am Acad Dermatol , vol.35 , pp. 671-674
    • Hann, S.K.1    Lee, H.J.2
  • 7
    • 0342633538 scopus 로고
    • Clinical study of 174 patients with generalized vitiligo
    • Hann SK, Park YK, Whang KC, et al. Clinical study of 174 patients with generalized vitiligo. Kor J Dermatol 1986; 24: 798-805.
    • (1986) Kor J Dermatol , vol.24 , pp. 798-805
    • Hann, S.K.1    Park, Y.K.2    Whang, K.C.3
  • 8
    • 1842414244 scopus 로고    scopus 로고
    • Clinical characteristics of progressive vitiligo
    • Hann SK, Chun WH, Park YK. Clinical characteristics of progressive vitiligo. Int J Dermatol 1997; 36: 353-355.
    • (1997) Int J Dermatol , vol.36 , pp. 353-355
    • Hann, S.K.1    Chun, W.H.2    Park, Y.K.3
  • 9
    • 0027751706 scopus 로고
    • The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients
    • Hann SK, Kim HI, Im S, et al. The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients. J Dermatol Sci 1993; 6: 201-205.
    • (1993) J Dermatol Sci , vol.6 , pp. 201-205
    • Hann, S.K.1    Kim, H.I.2    Im, S.3
  • 10
    • 0030019651 scopus 로고    scopus 로고
    • Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients
    • Park YK, Kim NS, Hann SK, et al. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients. J Dermatol Sci 1996; 9: 111-120.
    • (1996) J Dermatol Sci , vol.9 , pp. 111-120
    • Park, Y.K.1    Kim, N.S.2    Hann, S.K.3
  • 11
    • 0023910350 scopus 로고
    • Evidence for immunologic mechanisms in human vitiligo: Patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular toxicity
    • Norris DA, Kissinger RM, Naughton GM, et al. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular toxicity. J Invest Dermatol 1988; 90: 783-789.
    • (1988) J Invest Dermatol , vol.90 , pp. 783-789
    • Norris, D.A.1    Kissinger, R.M.2    Naughton, G.M.3
  • 12
    • 0025994610 scopus 로고
    • Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo
    • Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 1991; 97: 1078-1080.
    • (1991) J Invest Dermatol , vol.97 , pp. 1078-1080
    • Harning, R.1    Cui, J.2    Bystryn, J.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.